Where is Innovation in Health Care heading?
By Holger Adelmann, DIA EMEA
Is Europe geared up to provide an infrastructure to nurture Biotechs? The European Biotechnology Enterprises (EBE) has done a very critical assessment! Is the Pharma sector still attractive for investors or is IT largely eating in? Do we need innovative funding models?
Follow Holger on Twitter and LinkedIn for the latest articles
IN COLLABORATION WITH
